Xenex

company

About

Xenex offers Pulsed Xenon Full Spectrum, a UV disinfection solution that reduces the bacterial load associated with the risk for HAIs.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$38M
Industries
Health Care,Hospital,Medical Device,Robotics
Founded date
Jan 1, 2009
Number Of Employee
51 - 100
Operating Status
Active

Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections.

The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load often associated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S.

Xenex was founded in 2009 and headquartered in San Antonio, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$38M
Xenex has raised a total of $38M in funding over 2 rounds. Their latest funding was raised on Feb 24, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 24, 2017 Series Unknown $38M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Xenex is funded by 1 investors. Malin Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
Malin Corporation Series Unknown